VeriChip: Ready for a breakout?


Is VeriChip (NASDAQ: CHIP) ready for a massive breakout? I sure think so. Put aside for a moment the vast and potentially divisive implications of the technology and look at it in a strictly business sense. VeriChip offers technology that is absolutely bursting with potential. The chip, implanted just beneath the skin on a subject's arm, is dormant until scanned using a reader to extract the contained data. The chip costs about $200 to install, plus between $20 and $80 annually, depending on the amount of information on it.

Pets and farm animals are already being chipped as a means of loss prevention and for quick identification. Now volunteer Alzheimer's patients can elect to be chipped to facilitate location, identification and provision of medical information in the event that they wander off or are otherwise separated from guardians or loved ones. Patients with certain chronic life threatening diseases are being solicited as subjects for the device and there are rumors afloat in the UK that soon parents will be solicited to offer up their children to the technology. Yet to be approved by insurance companies as a covered procedure, the concept is still relatively new for use in people but based on the ongoing push by the company and its placement of chip readers in the hands of doctors, insurance company approval is strictly a matter of time.

With the simplicity and effectiveness of the silicon chip concept, however, come some possible negative issues that are very real. Some people claim that the very nature of location fixing technologies threatens our autonomy as individuals. For now the implantation of chips remains completely voluntary or a discretionary matter of personal safety for those who cannot choose to protect themselves. However, as evidenced on the British 9/11 forum, there are staunch defenders of the rights of personal freedom who are crying out in the wings that this is the first step to the total immersion of humanity into an establishment of complete institutional control. NewScientist.com has reported that religious groups have even protested the technology as a significant precursor to the "mark of the beast" as described in Christian literature.

All other considerations aside, one fact remains. VeriChip shares gained 27% last Friday with the news of the Alzheimer's patient chipping proposal. The technology is real and effective. It's safe, easy to implement and has significant benefits. The insurance companies are sure to approve coverage for these procedures as soon as VeriChip has assembled adequate data for the FDA and AMA. It's proven to work and the market is boundless.

I submit to you that right or wrong, my opinion is: "This one is going to fly."

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 01:28 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1329114517689 ms.